CFDE Data Portal | Search SNX5P1

	Label	Description
	SNX5P1 associations Collection (Entity type)	Associations for SNX5P1_associations
	SNX5P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SNX5P1 Gene (Entity type)	ENSG00000249858 - sorting nexin 5 pseudogene 1
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 6 v 10 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE120612 etoposide leukocyte 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE108464 AZ-628 11 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 5 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS

SNX5P1 associations

Associations for SNX5P1_associations

SNX5P1 associations.tsv

A file from IDG as part of the Harmonizome project

SNX5P1

ENSG00000249858 - sorting nexin 5 pseudogene 1

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

GSE108464 AZ-628 6 v 10 human up

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 5 v 3 human up

A Gene Set from LINCS

GSE226249 pirfenidone HL 2 v 4 human up

A Gene Set from LINCS

GSE120612 etoposide leukocyte 4 v 2 human dn

A Gene Set from LINCS

GSE108464 AZ-628 11 v 0 human dn

A Gene Set from LINCS

GSE226249 pirfenidone HL 5 v 8 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.